Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

医学 磁共振成像 冲程(发动机) 危险系数 安慰剂 内科学 心脏病学 中止 随机对照试验 放射科 病理 置信区间 机械工程 替代医学 工程类
作者
Eric Edward Smith,Ashkan Shoamanesh,Lizhen Xu,Laura Heenan,Feryal Saad,Pablo C. Colorado,Chih‐Hao Chen,Robin Lemmens,Gian Marco De Marchis,Valeria Caso,Jaime Masjuán,Teruyuki Hirano,Ivan Gospodinov Milanov,Bruce C.V. Campbell,Jean‐Louis Mas,Stuart J. Connolly,Hardi Mundl,Robert G. Hart,Peter Bailey,Bruce C.V. Campbell
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:55 (2): 392-402 被引量:15
标识
DOI:10.1161/strokeaha.123.043198
摘要

BACKGROUND: Exploratory analysis of the phase 2 PACIFIC-Stroke (Program of Anticoagulation via Inhibition of FXIa by the Oral Compound BAY 2433334-Non-Cardioembolic Stroke) randomized trial suggested that asundexian, an oral factor XIa inhibitor, prevents recurrent stroke and transient ischemic attacks in patients with atherosclerotic stroke. In this post hoc exploratory analysis, we hypothesized that asundexian would be more effective in patients enrolled with large, multiple, or cortical acute infarcts on magnetic resonance imaging than in patients enrolled with a single small subcortical acute infarct, and asundexian would prevent incident cortical covert infarcts. METHODS: In this placebo-controlled double-blinded randomized controlled trial, patients with mild-to-moderate noncardioembolic ischemic stroke were assigned to asundexian (10, 20, or 50 mg once daily) or placebo, in addition to antiplatelet therapy. Brain magnetic resonance imagings were required within 72 hours of randomization and repeated at 26 weeks or at discontinuation of the study drug. RESULTS: Of 1808 randomized patients, 1780 (98.5%) had interpretable baseline magnetic resonance imagings, of which 1628 (91.5%) had ≥1 diffusion-weighted imaging positive acute infarcts. Magnetic resonance imaging follow-up was obtained in 1439 patients, of whom 1358 had no symptomatic stroke during the trial period. Compared with placebo, asundexian 50 mg daily conferred a trend toward reduced risk of recurrent ischemic stroke or incident covert infarcts (hazard ratio, 0.71 [95% CI, 0.45-1.11]) and recurrent ischemic stroke or transient ischemic attack (secondary outcome; hazard ratio, 0.59 [95% CI, 0.33-1.06]) that was not evident in patients with single small subcortical infarcts (hazard ratios, 1.14 [95% CI, 0.62-2.10] and 0.93 [95% CI, 0.28-3.06]). Incident cortical covert infarcts were reduced in patients taking asundexian 50 mg, but the difference was not statistically significant (crude incidence ratio, 0.56 [95% CI, 0.28-1.12]). CONCLUSIONS: These exploratory, unconfirmed results suggest that asundexian may prevent new embolic infarcts but not small artery occlusion. The hypothesis that subtypes of covert brain infarcts respond differently to anticoagulant prevention should be tested in future trials. REGISTRATION: URL: https://clinicaltrials.gov; Unique identifier: NCT04304508.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
slidy完成签到,获得积分10
刚刚
静静的旋律完成签到 ,获得积分10
刚刚
2秒前
2秒前
英吉利25发布了新的文献求助10
3秒前
啦啦啦完成签到,获得积分10
3秒前
lan329完成签到,获得积分10
3秒前
yoga完成签到,获得积分10
4秒前
砖头完成签到 ,获得积分10
5秒前
5秒前
酷波er的应助被优雅的佳佳采纳,获得10
5秒前
小可爱完成签到 ,获得积分10
5秒前
西蓝花战士完成签到 ,获得积分10
6秒前
6秒前
黄橙子完成签到 ,获得积分10
6秒前
nicheng完成签到 ,获得积分10
7秒前
诗诗完成签到 ,获得积分10
7秒前
cc发布了新的文献求助10
8秒前
8秒前
茶餐厅完成签到 ,获得积分10
8秒前
liuguohua126完成签到,获得积分10
9秒前
mix完成签到 ,获得积分0
9秒前
寒冷的迎梦完成签到,获得积分10
9秒前
9秒前
11秒前
miemie66完成签到,获得积分10
11秒前
斯文凡旋发布了新的文献求助10
14秒前
14秒前
14秒前
寒冷的寄云完成签到,获得积分10
15秒前
15秒前
15秒前
冶金人完成签到,获得积分10
15秒前
wb完成签到,获得积分10
15秒前
开飞机的天天完成签到,获得积分10
16秒前
为常完成签到 ,获得积分10
16秒前
16秒前
风吹麦浪发布了新的文献求助100
17秒前
山岚完成签到 ,获得积分10
17秒前
66完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166653
求助须知:如何正确求助?哪些是违规求助? 9559595
关于积分的说明 21751026
捐赠科研通 7757480
什么是DOI,文献DOI怎么找? 3429172
关于科研通互助平台的介绍 2553536
邀请新用户注册赠送积分活动 2473931